A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
NCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT Number: NCT03252873
Investigators will compare the factors affecting the adherence to the outpatient pulmonary rehabilitation program in COPD patients
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Patients were referred to the Pulmonary Rehabilitation Unit and were recommended to participate in the exercise program by a team of experts included in this study.
Demographic and clinical characteristics of patients were recorded before the pulmonary rehabilitation program. All cases were evaluated by pulmonary function test, arterial blood gas analysis, six minute walking test, MMRC Dyspnea Scale. Causes that prevented program adaptation of those who did not participate in the program or who left the program were questioned. Patients completing the eight-week PR program will compare with those who did not complete the program or who did not start the program at the recommended time.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
COPD Patients referred to the outpatient pulmonary rehabilitation unit -
Exclusion criteria
To be unvolunteer
-
Time frame: 15 minutes
FEV1 (%) FEV1 /FVC TLCO (%) FEV1 (%), FEV1 /FVC, TLCO (%)
Time frame: 5 minutes
PAO2, PaCO2, SaO2
Time frame: 10 minutes
walking distance
Time frame: 5 minutes
1-5
Time frame: 20 minutes
Symptom-Activity-Impact- Total
Time frame: 15 minutes
Anxiety- Depression score
Izmir Katip Celebi University
Other
INVESTIGATION THE FACTORS AFFECTING THE ADHERENCE TO THE OUTPATIENT PULMONARY REHABILITATION PROGRAM IN COPD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT06614959
Bronchial Diseases, Bronchitis
Montreal, Quebec, Canada
View Trial DetailsNCT04754490
COPD, Chronic Disease
Abercynon, Wales, United Kingdom
View Trial DetailsNCT06336252
Arthritis, Basal Ganglia Diseases
Copenhagen, Denmark
View Trial Details